UPAR Induces Epithelial-mesenchymal Transition in Hypoxic Breast Cancer Cells

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2007 Aug 1

PMID 17664334

Citations 136

Authors

Robin D Lester

Minji Jo

Valerie Montel

Shinako Takimoto

Steven L Gonias

Affiliations

Soon will be listed here.

Abstract

Hypoxia activates genetic programs that facilitate cell survival; however, in cancer, it may promote invasion and metastasis. In this study, we show that breast cancer cells cultured in 1.0% O(2) demonstrate changes consistent with epithelial-mesenchymal transition (EMT). Snail translocates to the nucleus, and E-cadherin is lost from plasma membranes. Vimentin expression, cell migration, Matrigel invasion, and collagen remodeling are increased. Hypoxia-induced EMT is accompanied by increased expression of the urokinase-type plasminogen activator receptor (uPAR) and activation of cell signaling factors downstream of uPAR, including Akt and Rac1. Glycogen synthase kinase-3beta is phosphorylated, and Snail expression is increased. Hypoxia-induced EMT is blocked by uPAR gene silencing and mimicked by uPAR overexpression in normoxia. Antagonizing Rac1 or phosphatidylinositol 3-kinase also inhibits development of cellular properties associated with EMT in hypoxia. Breast cancer cells implanted on chick chorioallantoic membranes and treated with CoCl(2), to model hypoxia, demonstrate increased dissemination. We conclude that in hypoxia, uPAR activates diverse cell signaling pathways that cooperatively induce EMT and may promote cancer metastasis.

Citing Articles

Intricate relationship between cancer stemness, metastasis, and drug resistance.

Dakal T, Bhushan R, Xu C, Gadi B, Cameotra S, Yadav V MedComm (2020). 2024; 5(10):e710.

PMID: 39309691 PMC: 11416093. DOI: 10.1002/mco2.710.

Cancer spreading patterns based on epithelial-mesenchymal plasticity.

Wang R, Yan Z Front Cell Dev Biol. 2024; 12:1259953.

PMID: 38665432 PMC: 11043583. DOI: 10.3389/fcell.2024.1259953.

Plasminogen activator urokinase interacts with the fusion protein and antagonizes the growth of Peste des petits ruminants virus.

Wu J, Yang W, Li L, Wu J, He J, Ru Y J Virol. 2024; 98(4):e0014624.

PMID: 38440983 PMC: 11019896. DOI: 10.1128/jvi.00146-24.

Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity.

Portelli M, Bhaker S, Pang V, Bates D, Johnson S, Mazar A Clin Transl Allergy. 2023; 13(10):e12293.

PMID: 37876037 PMC: 10542610. DOI: 10.1002/clt2.12293.

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.

Casalino L, Talotta F, Matino I, Verde P Int J Mol Sci. 2023; 24(9).

PMID: 37176013 PMC: 10179602. DOI: 10.3390/ijms24098307.

References

Imai T, Horiuchi A, Wang C, Oka K, Ohira S, Nikaido T . Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol. 2003; 163(4):1437-47. PMC: 1868286. DOI: 10.1016/S0002-9440(10)63501-8. View

Zhang F, Tom C, Kugler M, Ching T, Kreidberg J, Wei Y . Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J Cell Biol. 2003; 163(1):177-88. PMC: 2173444. DOI: 10.1083/jcb.200304065. View

Bando H, Toi M, Kitada K, Koike M . Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed Pharmacother. 2003; 57(8):333-40. DOI: 10.1016/s0753-3322(03)00098-2. View

Semenza G . Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004; 19:176-82. DOI: 10.1152/physiol.00001.2004. View

Zhou B, Deng J, Xia W, Xu J, Li Y, Gunduz M . Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004; 6(10):931-40. DOI: 10.1038/ncb1173. View

Hayman E, Pierschbacher M, Ohgren Y, Ruoslahti E . Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A. 1983; 80(13):4003-7. PMC: 394188. DOI: 10.1073/pnas.80.13.4003. View

Zhou J, Schmid T, Schnitzer S, Brune B . Tumor hypoxia and cancer progression. Cancer Lett. 2005; 237(1):10-21. DOI: 10.1016/j.canlet.2005.05.028. View

Alfano D, Iaccarino I, Stoppelli M . Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels. J Biol Chem. 2006; 281(26):17758-67. DOI: 10.1074/jbc.M601812200. View

Conley B, Wright J, Kummar S . Targeting epigenetic abnormalities with histone deacetylase inhibitors. Cancer. 2006; 107(4):832-40. DOI: 10.1002/cncr.22064. View

10.

Wei Y, Tang C, Kim Y, Robillard L, Zhang F, Kugler M . Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells. J Biol Chem. 2006; 282(6):3929-39. DOI: 10.1074/jbc.M607989200. View

11.

Jo M, Thomas K, Takimoto S, Gaultier A, Hsieh E, Lester R . Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Oncogene. 2006; 26(18):2585-94. DOI: 10.1038/sj.onc.1210066. View

12.

Vial E, Sahai E, Marshall C . ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell. 2003; 4(1):67-79. DOI: 10.1016/s1535-6108(03)00162-4. View

13.

Schuster S, Badiavas E, Costa-Giomi P, Weinmann R, ERSLEV A, Caro J . Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. Blood. 1989; 73(1):13-6. View

14.

Wang G, Semenza G . General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A. 1993; 90(9):4304-8. PMC: 46495. DOI: 10.1073/pnas.90.9.4304. View

15.

Kiyan J, Kiyan R, Haller H, Dumler I . Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J. 2005; 24(10):1787-97. PMC: 1142599. DOI: 10.1038/sj.emboj.7600669. View

16.

Radisky D, Levy D, Littlepage L, Liu H, Nelson C, Fata J . Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 2005; 436(7047):123-7. PMC: 2784913. DOI: 10.1038/nature03688. View

17.

Thompson E, Newgreen D, Tarin D . Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?. Cancer Res. 2005; 65(14):5991-5. DOI: 10.1158/0008-5472.CAN-05-0616. View

18.

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

19.

Cheng J, Lindsley C, Cheng G, Yang H, Nicosia S . The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene. 2005; 24(50):7482-92. DOI: 10.1038/sj.onc.1209088. View

20.

Lester R, Jo M, Campana W, Gonias S . Erythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxia. J Biol Chem. 2005; 280(47):39273-7. DOI: 10.1074/jbc.M509446200. View